Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2026-04-09 @ 2:56 AM
Study NCT ID:
NCT01501968
Status:
UNKNOWN
Last Update Posted:
2011-12-30
First Post:
2011-12-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity
Sponsor:
Mahidol University
Organization:
Study Overview
Official Title:
Efficacy of Ascorbic Acid for Prevention of Colistin-Associated Nephrotoxicity
Status:
UNKNOWN
Status Verified Date:
2011-12
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ascorbic acid (Vitamin C) could protect renal toxicity from colistin.
Detailed Description:
Renal toxicity due to colistin therapy is common. Ascorbic acid (vitamin C) has been shown to prevent colistin associated renal toxicity in animals. This study is conducted to determine if acorbic acid can prevent Colistin-Associated Nephrotoxicity.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: